Zyvox Injection Dosage
Generic name: LINEZOLID 600mg in 300mL
Dosage form: injection, solution
Medically reviewed on July 31, 2018.
General Dosage and Administration
The recommended dosage for ZYVOX formulations for the treatment of infections is described in Table 1.
|Dosage, Route and Frequency of Administration||Recommended Duration of Treatment (consecutive days)|
|Infection*||Pediatric Patients† (Birth through 11 Years of Age)||Adults and Adolescents
(12 Years and Older)
|Nosocomial pneumonia||10 mg/kg intravenously or oral‡ every 8 hours
||600 mg intravenously or oral‡ every 12 hours
||10 to 14|
|Community-acquired pneumonia, including concurrent bacteremia|
|Complicated skin and skin structure infections|
|Vancomycin-resistant Enterococcus faecium infections, including concurrent bacteremia||10 mg/kg intravenously or oral‡ every 8 hours||600 mg intravenously or oral‡ every 12 hours||14 to 28|
|Uncomplicated skin and skin structure infections||less than 5 yrs: 10 mg/kg oral‡ every 8 hours
5–11 yrs: 10 mg/kg oral‡ every
|Adults: 400 mg oral‡ every 12 hours
Adolescents: 600 mg oral‡ every 12 hours
|10 to 14|
No dose adjustment is necessary when switching from intravenous to oral administration.
ZYVOX I.V. Injection is supplied in single-use, ready-to-use infusion bags. Parenteral drug products should be inspected visually for particulate matter prior to administration. Check for minute leaks by firmly squeezing the bag. If leaks are detected, discard the solution, as sterility may be impaired. Keep the infusion bags in the overwrap until ready to use. Each overwrap contains a peel-off label. Apply the peel-off label to the infusion bag for barcode scanning before use. Store at room temperature. Protect from freezing. ZYVOX I.V. Injection may exhibit a yellow color that can intensify over time without adversely affecting potency.
ZYVOX I.V. Injection should be administered by intravenous infusion over a period of 30 to 120 minutes. Do not use this intravenous infusion bag in series connections. Additives should not be introduced into this solution. If ZYVOX I.V. Injection is to be given concomitantly with another drug, each drug should be given separately in accordance with the recommended dosage and route of administration for each product.
If the same intravenous line is used for sequential infusion of several drugs, the line should be flushed before and after infusion of ZYVOX I.V. Injection with an infusion solution compatible with ZYVOX I.V. Injection and with any other drug(s) administered via this common line.
Compatible intravenous solutions include 0.9% Sodium Chloride Injection, USP, 5% Dextrose Injection, USP, and Lactated Ringer's Injection, USP.
Physical incompatibilities resulted when ZYVOX I.V. Injection was combined with the following drugs during simulated Y-site administration: amphotericin B, chlorpromazine HCl, diazepam, pentamidine isothionate, erythromycin lactobionate, phenytoin sodium, and trimethoprim-sulfamethoxazole. Additionally, chemical incompatibility resulted when ZYVOX I.V. Injection was combined with ceftriaxone sodium.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Zyvox (linezolid)
- Zyvox Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 26 Reviews
- Generic Availability
- Drug class: oxazolidinone antibiotics
- FDA Alerts (4)
- Zyvox (Linezolid Injection)
- Zyvox (Linezolid Suspension)
- Zyvox (Linezolid Tablets)
- Zyvox (Advanced Reading)
- Zyvox Intravenous (Advanced Reading)